57 related articles for article (PubMed ID: 9580608)
1. 5-Hydroxytryptamine2 receptors modulate auditory filtering in the rat.
Johnson RG; Stevens KE; Rose GM
J Pharmacol Exp Ther; 1998 May; 285(2):643-50. PubMed ID: 9580608
[TBL] [Abstract][Full Text] [Related]
2. The 5-HT(1A) receptor active compounds (R)-8-OH-DPAT and (S)-UH-301 modulate auditory evoked EEG responses in rats.
Stevens KE; O'Neill HC; Rose GM; Luthman J
Amino Acids; 2006 Nov; 31(4):365-75. PubMed ID: 16868646
[TBL] [Abstract][Full Text] [Related]
3. Noradrenergic antagonism of the P13 and N40 components of the rat auditory evoked potential.
Keedy SK; Marlow-O'Connor M; Beenken B; Dorflinger J; Abel M; Erwin RJ
Psychopharmacology (Berl); 2007 Jan; 190(1):117-25. PubMed ID: 17096083
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical increase of 5-hydroxytryptamine2 receptors and 5-hydroxytryptamine2 receptor mRNA in cerebellar granule cells after persistent 5-hydroxytryptamine2 receptor stimulation.
Akiyoshi J; Hough C; Chuang DM
Mol Pharmacol; 1993 Mar; 43(3):349-55. PubMed ID: 8383800
[TBL] [Abstract][Full Text] [Related]
5. Modulation of mGlu2 Receptors, but Not PDE10A Inhibition Normalizes Pharmacologically-Induced Deviance in Auditory Evoked Potentials and Oscillations in Conscious Rats.
Ahnaou A; Biermans R; Drinkenburg WH
PLoS One; 2016; 11(1):e0147365. PubMed ID: 26808689
[TBL] [Abstract][Full Text] [Related]
6. Nicotinic cholinergic normalization of amphetamine-induced loss of auditory gating in freely moving rats.
Stevens KE; Meltzer J; Rose GM
Psychopharmacology (Berl); 1995 May; 119(2):163-70. PubMed ID: 7659763
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.
Pierce PA; Peroutka SJ
J Pharmacol Exp Ther; 1988 Dec; 247(3):918-25. PubMed ID: 3204523
[TBL] [Abstract][Full Text] [Related]
8. Auditory evoked potentials in the detection of interaural intensity differences in children and adults.
Wambacq IJ; Koehnke J; Shea-Miller KJ; Besing J; Toth V; Abubakr A
Ear Hear; 2007 Jun; 28(3):320-31. PubMed ID: 17485981
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiological characterization of 5-hydroxytryptamine2 receptors in the rat medial prefrontal cortex.
Ashby CR; Jiang LH; Kasser RJ; Wang RY
J Pharmacol Exp Ther; 1990 Jan; 252(1):171-8. PubMed ID: 2137174
[TBL] [Abstract][Full Text] [Related]
10. Kainic acid lesions in adult rats as a model of schizophrenia: changes in auditory information processing.
Stevens KE; Nagamoto H; Johnson RG; Adams CE; Rose GM
Neuroscience; 1998 Feb; 82(3):701-8. PubMed ID: 9483529
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
Moxon KA; Gerhardt GA; Adler LE
Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
[TBL] [Abstract][Full Text] [Related]
12. Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells.
Ferry RC; Unsworth CD; Molinoff PB
Mol Pharmacol; 1993 May; 43(5):726-33. PubMed ID: 8388988
[TBL] [Abstract][Full Text] [Related]
13. Central and peripheral mechanisms in the stimulation of adrenocortical secretion by the 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane.
Welch JE; Saphier D
J Pharmacol Exp Ther; 1994 Sep; 270(3):918-28. PubMed ID: 7932204
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the gating of auditory evoked potentials by norepinephrine: pharmacological evidence obtained using a selective neurotoxin.
Adler LE; Pang K; Gerhardt G; Rose GM
Biol Psychiatry; 1988 Jun; 24(2):179-90. PubMed ID: 3390498
[TBL] [Abstract][Full Text] [Related]
15. 5-Hydroxytryptamine2 receptor facilitates GABAergic neurotransmission in rat hippocampus.
Shen RY; Andrade R
J Pharmacol Exp Ther; 1998 May; 285(2):805-12. PubMed ID: 9580630
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
17. [Serotonergic mechanisms of hippocampal kindled seizures in cats--effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and ketanserin].
Nakamura M; Wada Y; Hasegawa H; Yamaguchi N
No To Shinkei; 1993 Oct; 45(10):935-9. PubMed ID: 8268033
[TBL] [Abstract][Full Text] [Related]
18. DOI and alpha-methylserotonin: comparative vascular and nonvascular smooth muscle effects and central 5-hydroxytryptamine2 receptor affinities.
Cohen ML; Johnson MP; Schenck KW; Susemichel A; Wainscott DB; Robertson DW; Nelson DL
J Pharmacol Exp Ther; 1993 Aug; 266(2):943-9. PubMed ID: 8355216
[TBL] [Abstract][Full Text] [Related]
19. Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor.
Smith RL; Barrett RJ; Sanders-Bush E
J Pharmacol Exp Ther; 1995 Nov; 275(2):1050-7. PubMed ID: 7473132
[TBL] [Abstract][Full Text] [Related]
20. 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes.
Teitler M; Leonhardt S; Weisberg EL; Hoffman BJ
Mol Pharmacol; 1990 Nov; 38(5):594-8. PubMed ID: 2233696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
